International Centre For Diarrhoeal Disease Research, Bangladesh
Clinical trials sponsored by International Centre For Diarrhoeal Disease Research, Bangladesh, explained in plain language.
-
Old drug, new target: can ivermectin cure a stubborn skin parasite?
Disease control CompletedThis study tested if the drug ivermectin, taken by mouth, is a safe and effective treatment for Post-Kala-Azar Dermal Leishmaniasis (PKDL), a skin disease caused by parasites. It compared ivermectin given over three months to the standard 12-week miltefosine treatment in 30 patie…
Phase: EARLY_PHASE1 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Common drug tested for stubborn skin disease
Disease control CompletedThis small, early study tested if the drug ivermectin, taken by mouth, is safe and can help treat Post Kala-Azar Dermal Leishmaniasis (PKDL). PKDL is a skin condition that can appear after someone recovers from kala-azar (visceral leishmaniasis). The study involved 10 participant…
Phase: EARLY_PHASE1 • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
Does early help for moms boost Kids' brains years later?
Knowledge-focused CompletedThis study followed up on children in Bangladesh to see if a program from their infancy had lasting effects. The original program gave some mothers parenting guidance along with small cash payments, while others received only cash. Researchers checked years later, when the childr…
Phase: NA • Sponsor: International Centre for Diarrhoeal Disease Research, Bangladesh • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC